Malvyn Pharmaceuticals Private Limited, a active private limited company, was established on 07 April 2016 in Allahabad, Uttar Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U33301UP2016PTC082585. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Rajprakash Srinarayan Mishra (Additional Director), Suresh Chandra Mishra (Director), Harsh Rajprakash Mishra (Additional Director). Past directors included Rajprakash Srinarayan Mishra. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 138/11C Chota Bhagara, Allahabad, Uttar Pradesh, 211003.
U33301UP2016PTC082585
082585
07 April 2016
₹1.00 M
₹0.50 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Malvyn Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajprakash Srinarayan Mishra | Additional Director | 10 Mar 2022 | Current |
| Suresh Chandra Mishra | Director | 07 Apr 2016 | Current |
| Harsh Rajprakash Mishra | Additional Director | 13 Aug 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Aug 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Malvyn Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 23.45% decrease. The company also saw a substantial improvement in profitability, with a 17.39% increase in profit. The company's net worth observed a substantial decline by a decrease of 121.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Malvyn Pharmaceuticals had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Malvyn Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Malvyn Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Malvyn Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Malvyn Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Malvyn Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
Progress on Rajprakash Srinarayan Mishra was appointed as a Additional Director was appointed as a Additional Director on 10 Mar 2022 & has been associated with this company since 3 years 8 months . was documented.
Progress on Harsh Rajprakash Mishra was appointed as a Additional Director was appointed as a Additional Director on 13 Aug 2019 & has been associated with this company since 6 years 3 months . was documented.
The activity Suresh Chandra Mishra was appointed as a Director was appointed as a Director on 07 Apr 2016 & has been associated with this company since 9 years 7 months . was completed.
The activity Malvyn Pharmaceuticals Private Limited was registered on 07 Apr 2016 with Roc Kanpur & aged 9 years 7 months as per MCA records. was completed.
The CIN of Malvyn Pharmaceuticals Private Limited is U33301UP2016PTC082585.
Malvyn Pharmaceuticals Private Limited is headquartered at 138/11C Chota Bhagara, Allahabad, Uttar Pradesh, 211003.
Malvyn Pharmaceuticals Private Limited was incorporated on 07 April 2016.
The current directors of Malvyn Pharmaceuticals Private Limited are
The primary industry of Malvyn Pharmaceuticals Private Limited is Trade.
Malvyn Pharmaceuticals Private Limited is unlisted.
The authorized capital of Malvyn Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Malvyn Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX